hydralazine and enalapril

hydralazine has been researched along with enalapril in 102 studies

Research

Studies (102)

Timeframe	Studies, this research(%)	All Research%
pre-1990	24 (23.53)	18.7374
1990's	51 (50.00)	18.2507
2000's	21 (20.59)	29.6817
2010's	6 (5.88)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Cleary, EG; King, RA; Krishnan, R; Smith, RM	1
Campbell, TJ	1
Blanc, J; Deckert, V; Elghozi, JL; Grichois, ML	1
Fujihara, CK; Padilha, RM; Zatz, R	1
Armitage, JM; Griffith, BP; Hardesty, RL; Kormos, RL; Lee, A; Schechter, D; Ziady, GM	1
Nowack, R; Ritz, E	1
Cohn, JN	4
Cobb, F; Cohn, JN; Dunkman, WB; Francis, G; Johnson, G; Loeb, H; Smith, R; Tristani, F; Wong, M; Ziesche, S	1
Fogo, A; Ichikawa, I; Yared, A; Yoshida, Y	1
Hirata, Y; Inada, M; Matsubara, H; Mori, Y; Oikawa, S; Yamamoto, J	1
Ganten, D; Hellmann, T; Keuneke, C; Metzger, R; Peters, J; Yacullo, R	1
Ambrosioni, E; Cinotti, G; Cuspidi, C; Leonetti, G; Malini, PL; Morabito, S; Pessina, A; Rappelli, A; Sampieri, L; Semplicini, A	1
Inariba, H; Inoue, T; Itoh, S; Kanayama, Y; Takaori, K; Takeda, T	1
Allen, TJ; Clarke, BE; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Papazoglou, D	1
Bühlmayer, P; Criscione, L; de Gasparo, M; Jupp, RA; Kay, J; Rüeger, H; Stanton, JL; Wood, JM	1
Dworkin, LD; Feiner, HD; Grosser, M; Parker, M; Ullian, M	1
Lee, HC; Mitchell, HC; Pettinger, WA; Redman, HC	1
Drummer, OH; Froomes, P; McLean, AJ; McNeil, JJ; Smith, HJ	1
Fogo, A; Ichikawa, I; Ikoma, M; Kawamura, T; Yoshida, Y	1
Baba, T; Sawicki, PT	1
Raij, L; Shultz, PJ	1
Kloner, RA; Przyklenk, K	1
Hutchinson, FN; Kaysen, GA; Schambelan, M	1
Francis, GS	1
Azizi, M; Levy, B; Ménard, J; Michel, JB; Salzmann, JL	1
Hartmann, JF; Hayes, NS; Keegan, ME; Slater, EE; Szemplinski, M	1
Fujii, S; Kawaguchi, H; Okamoto, H; Saito, H; Togashi, H; Yasuda, H	1
Bluth, R; Langnickel, R	1
Levine, TB	2
Chan, CC; Ford-Hutchinson, A	1
Franklin, SS; Smith, RD	2
Chiou, XC; Owens, R; Raij, L; Wrigley, B	1
Anderson, S; Brenner, BM; Rennke, HG	1
Artman, M; Graham, TP	1
Fyhrquist, F; Grönhagen-Riska, C; Karlberg, BE; Ohman, KP; Tikkanen, I	1
Fernandez, PG; Galway, AB; Kim, BK	1
Andoh, TF; Bennett, WM; Burdmann, EA; Coffman, TM; Connors, BA; Evan, A; Lindsley, J; Nast, CC	1
Giles, TD	1
Doohan, MM; Hool, LC; Rasmussen, HH; Whalley, DW	1
Chang, MS; Cheitlin, MD; Chiang, BN; Chiang, HT; Kuo, HW; Lin, M; Lin, SL	1
Fukui, T; Horio, T; Kohno, M; Kurihara, N; Takeda, T; Yasunari, K; Yokokawa, K; Yoshiyama, M	1
Naish, PF; Odum, J; Purkiss, J	1
Baba, N; Sakemi, T	1
Carson, PE; Cohn, JN; Dunkman, WB; Farrell, L; Fletcher, RD; Johnson, GR	1
Cohn, JN; Hughes, CV; Johnson, G; Wong, M	1
Cintron, G; Cobb, F; Cohn, JN; Francis, G; Johnson, G	1
Cintron, G; Cohn, JN; Francis, G; Goldman, S; Johnson, G; Smith, R	1
Carson, P; Cohn, JN; Francis, GS; Johnson, G	1
Cohn, JN; Francis, GS; Goldman, S; Johnson, G; Rector, TS; Simon, A	1
Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J	1
Cohn, JN; Fletcher, R; Johnson, GR; Loeb, H; Rector, T; Shabetai, R; Smith, R; Tristani, F	1
Cobb, FR; Cohn, JN; Johnson, G; Tristani, F; Ziesche, S	1
Bhat, G; Cohn, JN; Hughes, V; Johnson, G; Lopez, B; Shabetai, R; Wong, M	1
Cohn, JN; Daniels, G; Dunkman, WB; Farrell, L; Henrick, A; Johnson, G; Rector, TS; Smith, B	1
Cohn, JN; Cremo, R; Henrick, A; Johnson, G; Loeb, HS; Smith, R; Wilson, J	1
Bhat, G; Carson, PE; Cohn, JN; Dunkman, WB; Farrell, L; Johnson, GR	1
Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K	1
Fukui, M; Sekizuka, K; Shirato, I; Shou, I; Suzuki, S; Tomino, Y; Wang, LN; Yamamoto, M	1
Agostoni, P; Alimento, M; Contini, M; Guazzi, M; Marenzi, G	1
Anderson, IK; Drew, GM	1
Catanese, VM; Donohue, TJ; Dworkin, LD; Lango, MN; Ma, J	1
Takahashi, M; Uehara, Y	1
Allen, LV; Erickson, MA	1
Dam, TV; deBlois, D; Hamet, P; Moreau, P; Tea, BS	1
Carson, P; Cohn, JN; Johnson, G; Ziesche, S	1
Bakhtiarian, A; Djahanguiri, B; Rahgozar, M; Toroudi, HP	1
Al-Nimri, MA; Anderson, S; Chapman, JG; Kelly, FJ; Kennefick, TM; Oyama, TT; Thompson, MM	1
Armini, L; Bardelli, M; Calci, M; Campanacci, L; Candido, R; Carretta, R; Fabris, B; Fazio, M; Fischetti, F	1
Abe, I; Fujii, K; Fujishima, M; Goto, K; Onaka, U	1
Esposito, G; Fox, JE; Hagaman, JR; Knowles, JW; Maeda, N; Mao, L; Rockman, HA; Smithies, O	1
Abe, I; Kagiyama, S; Lin, Y; Matsumura, K; Tsuchihashi, T	1
Adams, MA; Hale, TM; Heaton, JP; Okabe, H	1
Cardin, S; Leung, TK; Li, D; Nattel, S; Pang, L; Shinagawa, K; Wang, Z	1
Cheon, HW; Choi, JH; Hong, YS; Kim, CH; Kim, KB; Kim, SK; Lee, JW; Yoo, KH	1
Adams, MA; Bushfield, TL; Hale, TM; Woolard, J	1
Afzal, R; Anker, SD; Coats, AJ; Cohn, JN; Negassa, A; Poole-Wilson, PA; Yusuf, S	1
Arens, T; Dendorfer, A; Dominiak, P; Häuser, W; Qadri, F; Schwarz, EC	1
Bidani, AK; Griffin, KA; Picken, MM	1
Bloche, MG	1
Drazner, MH; Wallace, TW	1
Adams, MA; Hale, TM; Hannan, JL; Heaton, JP; Smallegange, C	1
Bates, JN; Hashmi-Hill, MP; Lewis, SJ; Owen, JR; Robertson, TP; Sandock, K	1
Ginsburg, GS; Haga, SB	1
Elewa, HF; Ergul, A; Fagan, SC; Johnson, MH; Kozak, A	1
Leong, PK; McDonough, AA; Yang, LE	1
Abreu, GR; Bissoli, NS; de Andrade, TU; de Melo Cabral, A; Moysés, MR	1
Hayashi, K; Ishiguro, K; Itoh, H; Sakamaki, Y; Sasamura, H	1
Abdel-Rahman, AA; El-Mas, MM	1
Bidani, AK; Griffin, KA; Litbarg, N; Picken, M; Polichnowski, A; Venkatachalam, MA	1
Cao, YM; Gao, WH; Hu, JW; Lv, YB; Mu, JJ; Wang, Y; Xie, BQ; Yan, DY; Yuan, ZY; Zheng, WL	1
Chams, N; Gjeka, R; Kumar, S; Peterson, D; Ross, I; Salman, A; Salman, J; Tegeltija, V	1

Reviews

10 review(s) available for hydralazine and enalapril

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Detrimental and beneficial effects of converting enzyme inhibitors on the kidney. Journal of cardiovascular pharmacology, 1990, Volume: 16 Suppl 4 Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Humans; Hydralazine; Kidney	1990
Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure. Herz, 1991, Volume: 16 Spec No 1 Topics: Enalapril; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Survival Rate; Vasodilator Agents	1991
Studies of Left Ventricular Dysfunction (SOLVD)--new hope for heart failure. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1991, Nov-02, Volume: Suppl Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Stroke Volume; Survival Rate	1991
Heart failure management: the impact of drug therapy on survival. American heart journal, 1988, Volume: 115, Issue:3 Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors	1988
Current concepts in the treatment of congestive heart failure. British journal of clinical pharmacology, 1984, Volume: 18 Suppl 2 Topics: Calcium Channel Blockers; Captopril; Digitalis Glycosides; Dipeptides; Diuretics; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Hypernatremia; Isosorbide Dinitrate; Nitroprusside; Prazosin; Vasoconstriction	1984
Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III. Drugs, 1994, Volume: 47 Suppl 4 Topics: Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Exercise; Felodipine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Oxygen Consumption; Prognosis; Stroke Volume; Survival Analysis	1994
Plasma norepinephrine and mortality. Clinical cardiology, 1995, Volume: 18, Issue:3 Suppl I Topics: Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Prognosis; Sympathetic Nervous System; Ventricular Dysfunction, Left	1995
Optimizing the treatment of heart failure. Current opinion in cardiology, 1994, Volume: 9 Suppl 1 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume	1994
The impact of race on response to RAAS inhibition. Current heart failure reports, 2005, Volume: 2, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Clinical Trials as Topic; Diuretics, Osmotic; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide; Vasodilator Agents; Ventricular Dysfunction, Left; White People	2005

Trials

30 trial(s) available for hydralazine and enalapril

Article	Year
V-HeFT positive for enalapril. British journal of hospital medicine, 1991, Volume: 45, Issue:4 Topics: Adolescent; Adult; Aged; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged	1991
Studies of Left Ventricular Dysfunction (SOLVD)--new hope for heart failure. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1991, Nov-02, Volume: Suppl Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Stroke Volume; Survival Rate	1991
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. The New England journal of medicine, 1991, Aug-01, Volume: 325, Issue:5 Topics: Adolescent; Adult; Aged; Chronic Disease; Death, Sudden; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Patient Compliance; Physical Exertion; Stroke Volume; Survival Rate	1991
Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study. Journal of human hypertension, 1990, Volume: 4, Issue:1 Topics: Blood Pressure; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Multicenter Studies as Topic; Propranolol; Randomized Controlled Trials as Topic	1990
Pseudo renal artery stenosis (PRAS) syndrome. American journal of hypertension, 1989, Volume: 2, Issue:5 Pt 1 Topics: Angiography; Blood Pressure; Body Weight; Creatinine; Double-Blind Method; Enalapril; Humans; Hydralazine; Hypertension; Minoxidil; Nephrosclerosis; Prospective Studies; Random Allocation; Renal Artery; Renal Artery Obstruction; Renin; Syndrome	1989
Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine. Journal of human hypertension, 1989, Volume: 3 Suppl 1 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Interactions; Drug Therapy, Combination; Enalapril; Humans; Hydralazine; Lisinopril; Male	1989
Heart failure management: the impact of drug therapy on survival. American heart journal, 1988, Volume: 115, Issue:3 Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors	1988
Role of vasodilators in the treatment of congestive heart failure. The American journal of cardiology, 1985, Jan-11, Volume: 55, Issue:2 Topics: Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Random Allocation; Regional Blood Flow; Vascular Resistance; Vasodilator Agents	1985
Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. The American journal of medicine, 1985, Sep-27, Volume: 79, Issue:3C Topics: Adult; Aged; Blood Pressure; Enalapril; Female; Glomerular Filtration Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Male; Middle Aged; Renal Circulation; Timolol	1985
A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension. Nephron, 1986, Volume: 44 Suppl 1 Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Male; Middle Aged; Patient Dropouts; Prospective Studies; Random Allocation; Timolol	1986
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report. Scandinavian journal of urology and nephrology. Supplementum, 1984, Volume: 79 Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dipeptides; Enalapril; Humans; Hydralazine; Hypertension, Renovascular; Lisinopril; Middle Aged; Prazosin	1984
An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension. Pharmatherapeutica, 1984, Volume: 3, Issue:8 Topics: Adult; Antihypertensive Agents; Clinical Trials as Topic; Dipeptides; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol	1984
Plasma norepinephrine and mortality. Clinical cardiology, 1995, Volume: 18, Issue:3 Suppl I Topics: Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Prognosis; Sympathetic Nervous System; Ventricular Dysfunction, Left	1995
Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. Journal of the American College of Cardiology, 1994, Volume: 24, Issue:4 Topics: Aged; Aortic Valve Insufficiency; Chronic Disease; Double-Blind Method; Echocardiography; Enalapril; Female; Follow-Up Studies; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Renin-Angiotensin System; Vasodilator Agents; Ventricular Function, Left	1994
The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Prazosin; Research Design; Survival Analysis; Vasodilator Agents	1993
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Atrial Fibrillation; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Morbidity; Prazosin; Prognosis; Risk Factors	1993
Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Age Factors; Aged; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Survival Analysis	1993
Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Stroke Volume; Survival Analysis; Ventricular Function, Left	1993
Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Cause of Death; Death, Sudden, Cardiac; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Risk Factors; Survival Analysis	1993
Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Risk Factors; Survival Analysis	1993
Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Renin; Risk Factors; Survival Analysis	1993
Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prevalence; Risk Factors; Tachycardia, Ventricular	1993
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Arrhythmias, Cardiac; Cardiomegaly; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Prazosin; Prognosis; Stroke Volume; Ventricular Function, Left	1993
Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Anaerobic Threshold; Drug Therapy, Combination; Enalapril; Exercise Test; Exercise Tolerance; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin	1993
Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Drug Therapy, Combination; Echocardiography; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Survival Analysis; Ventricular Function, Left	1993
Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Attitude to Health; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Quality of Life; Surveys and Questionnaires	1993
Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Risk Factors; Time Factors	1993
Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation, 1993, Volume: 87, Issue:6 Suppl Topics: Cerebrovascular Disorders; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Incidence; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation Inhibitors; Prazosin; Thromboembolism; Warfarin	1993
Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation, 1997, Apr-01, Volume: 95, Issue:7 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood-Air Barrier; Bradykinin; Cyclooxygenase Inhibitors; Diffusion; Double-Blind Method; Enalapril; Epoprostenol; Exercise Test; Female; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Alveoli; Pulmonary Circulation; Pulmonary Gas Exchange; Respiratory Function Tests	1997
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. Journal of cardiac failure, 1999, Volume: 5, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Double-Blind Method; Drug Therapy, Combination; Enalapril; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Renin; Retrospective Studies; Survival Rate; Treatment Outcome; Vasodilator Agents; White People	1999

Other Studies

65 other study(ies) available for hydralazine and enalapril

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Effects of enalapril and hydralazine treatment and withdrawal upon cardiovascular hypertrophy in stroke-prone spontaneously hypertensive rats. Journal of hypertension, 1992, Volume: 10, Issue:9 Topics: Animals; Blood Pressure; Body Weight; DNA; Elastin; Enalapril; Heart Ventricles; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Artery, Superior; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Vascular Resistance	1992
Recent developments in the pharmacotherapy of cardiac failure. The Medical journal of Australia, 1992, Sep-07, Volume: 157, Issue:5 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Digoxin; Diuretics; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Vasodilator Agents	1992
Differential effects of enalapril and hydralazine on short-term variability of blood pressure and heart rate in rats. Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Drinking Behavior; Enalapril; Heart Rate; Hydralazine; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Renin-Angiotensin System	1992
Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy. Diabetes, 1992, Volume: 41, Issue:3 Topics: Albuminuria; Analysis of Variance; Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Hydralazine; Hypertension; Kidney Glomerulus; Male; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Vascular Resistance	1992
Efficacy of antihypertensive medication in orthotopic heart transplant recipients and its effect on renal function. Angiology, 1992, Volume: 43, Issue:7 Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Urea Nitrogen; Creatinine; Enalapril; Female; Heart Transplantation; Humans; Hydralazine; Kidney; Male; Middle Aged; Retrospective Studies	1992
Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney international, 1990, Volume: 38, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Hydralazine; Kidney Glomerulus; Male; Rats; Verapamil	1990
Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats. Circulation research, 1990, Volume: 66, Issue:1 Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blotting, Northern; Cardiomegaly; Enalapril; Heart Ventricles; Hemodynamics; Hydralazine; Hypertension, Renovascular; Male; Nephrectomy; Rats; Rats, Inbred Strains; RNA, Messenger; Time Factors	1990
The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition. European heart journal, 1990, Volume: 11 Suppl D Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Gene Expression Regulation; Heart; Hydralazine; Hypertension; Isoquinolines; Kidney; Lisinopril; Male; Quinapril; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrahydroisoquinolines	1990
Chronic antihypertensive drug treatment decreases protein kinase C activity in platelets from SHR. Clinical and experimental hypertension. Part A, Theory and practice, 1990, Volume: 12, Issue:6 Topics: Animals; Antihypertensive Agents; Blood Platelets; Enalapril; Hydralazine; Male; Nifedipine; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors	1990
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. Diabetes, 1990, Volume: 39, Issue:12 Topics: Administration, Oral; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Hydralazine; Hypertension; Kidney; Kidney Glomerulus; Male; Metoprolol; Rats; Rats, Inbred SHR	1990
CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity. Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:2 Topics: Animals; Blood Pressure; Callitrichinae; Enalapril; Female; Humans; Hydralazine; In Vitro Techniques; Male; Molecular Weight; Oligopeptides; Protease Inhibitors; Renin; Swine; Time Factors	1989
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney international, 1989, Volume: 35, Issue:3 Topics: Animals; Antihypertensive Agents; Captopril; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Renal Circulation; Reserpine	1989
Effects of antihypertensive drugs on glomerular morphology. Kidney international, 1989, Volume: 36, Issue:4 Topics: Animals; Antihypertensive Agents; Enalapril; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hydralazine; Hydrochlorothiazide; Hypertrophy; Kidney Glomerulus; Male; Rats; Renal Circulation; Reserpine	1989
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril? Diabetologia, 1989, Volume: 32, Issue:11 Topics: Albuminuria; Animals; Basement Membrane; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Hydralazine; Hypertension; Kidney Glomerulus; Metoprolol; Rats	1989
Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations. British journal of clinical pharmacology, 1989, Volume: 28 Suppl 2 Topics: Acetylcholine; Adenosine Diphosphate; Administration, Oral; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Captopril; Enalapril; Hydralazine; Indomethacin; Male; Nitric Oxide; Pyrogallol; Rats; Rats, Inbred Strains	1989
Acute effects of hydralazine and enalapril on contractile function of postischemic "stunned" myocardium. The American journal of cardiology, 1987, Oct-01, Volume: 60, Issue:10 Topics: Animals; Dogs; Enalapril; Hemodynamics; Hydralazine; Myocardial Contraction; Myocardial Infarction; Time Factors	1987
Modulation of albuminuria by dietary protein and converting enzyme inhibition. The American journal of physiology, 1987, Volume: 253, Issue:4 Pt 2 Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Dietary Proteins; Enalapril; Hydralazine; Male; Nephrosis; Rats; Rats, Inbred Strains	1987
Effect of vasodilatators on the structure of the aorta in normotensive ageing rats. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1987, Volume: 5, Issue:5 Topics: Aging; Animals; Aorta; Arteries; Blood Pressure; Collagen; Dihydralazine; Elastin; Enalapril; Hydralazine; Male; Rats; Rats, Inbred Strains	1987
Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. Journal of hypertension, 1988, Volume: 6, Issue:8 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Enalapril; Hydralazine; Hypertension; Lisinopril; Rats; Renin; Renin-Angiotensin System; Streptozocin	1988
Fatty acid binding protein of cardiac muscle in spontaneously hypertensive rats: effect of hypertrophy and its regression. Journal of molecular and cellular cardiology, 1988, Volume: 20, Issue:9 Topics: Animals; Blood Pressure; Cardiomegaly; Carrier Proteins; Enalapril; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Hydralazine; Hypertension; Male; Myocardium; Neoplasm Proteins; Nerve Tissue Proteins; Nicardipine; Rats; Rats, Inbred SHR	1988
[Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators]. Zeitschrift fur arztliche Fortbildung, 1985, Volume: 79, Issue:19 Topics: Adrenergic alpha-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Coronary Disease; Diazoxide; Drug Tolerance; Enalapril; Hemodynamics; Humans; Hydralazine; Hypertension; Minoxidil; Muscle, Smooth; Nitroglycerin; Vasodilator Agents	1985
Potentiation of the inhibitory effect of a thromboxane A2 antagonist (L-640,035) on arterial thrombosis formation in rabbit by the angiotensin converting enzyme inhibitor enalapril. European journal of pharmacology, 1985, Apr-16, Volume: 110, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Dibenzothiepins; Dipeptides; Drug Synergism; Enalapril; Female; Hexamethonium Compounds; Hydralazine; Male; Prostaglandin Antagonists; Rabbits; Radioimmunoassay; Thrombosis; Thromboxane A2; Thromboxanes	1985
Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model. The American journal of medicine, 1985, Sep-27, Volume: 79, Issue:3C Topics: Animals; Enalapril; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR; Reserpine	1985
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. The Journal of clinical investigation, 1986, Volume: 77, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; Microcirculation; Natriuresis; Proteinuria; Rats; Renin; Renin-Angiotensin System; Reserpine	1986
Guidelines for vasodilator therapy of congestive heart failure in infants and children. American heart journal, 1987, Volume: 113, Issue:4 Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Infant; Nifedipine; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents	1987
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. The American journal of physiology, 1995, Volume: 269, Issue:4 Pt 2 Topics: Animals; Biphenyl Compounds; Blood Pressure; Cyclosporine; Enalapril; Furosemide; Hydralazine; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles	1995
Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytes. The American journal of physiology, 1995, Volume: 268, Issue:2 Pt 1 Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Heart; Hydralazine; Hydrogen-Ion Concentration; Intracellular Membranes; Male; Myocardium; Rabbits; Sarcolemma; Sodium; Sodium-Potassium-Exchanging ATPase; Time Factors	1995
Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension. The American journal of physiology, 1994, Volume: 266, Issue:2 Pt 2 Topics: Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Blood Urea Nitrogen; Cardiomegaly; Chromatography, High Pressure Liquid; Creatinine; Desoxycorticosterone; Enalapril; Heart; Hydralazine; Hypertension, Malignant; Imidazoles; Losartan; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred SHR; Sodium, Dietary; Tetrazoles	1994
Influence of differing classes of antihypertensive agents on mesangial kinetics following partial renal ablation in rats. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:2 Topics: Albuminuria; Animals; Antihypertensive Agents; Biological Transport, Active; Enalapril; Glomerular Mesangium; Hydralazine; Hydrochlorothiazide; Hypertrophy; Kidney Glomerulus; Kinetics; Male; Nephrectomy; Rats; Rats, Wistar; Reserpine; Serum Albumin, Bovine; Tissue Distribution	1994
Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats. Nephron, 1993, Volume: 63, Issue:3 Topics: Animals; Antihypertensive Agents; Cholesterol; Drug Therapy, Combination; Enalapril; Hydralazine; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Male; Proteinuria; Rats; Reserpine; Time Factors	1993
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. American journal of veterinary research, 1996, Volume: 57, Issue:11 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Diseases; Dogs; Echocardiography; Enalapril; Female; Furosemide; Heart Failure; Heart Rate; Hydralazine; Male; Mitral Valve Insufficiency; Renin-Angiotensin System; Vasodilator Agents; Water-Electrolyte Balance	1996
Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats. Journal of clinical laboratory analysis, 1997, Volume: 11, Issue:1 Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Creatinine; Enalapril; Glomerulonephritis; Hydralazine; Hydrochlorothiazide; Imidazoles; Kidney; Kidney Glomerulus; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Reserpine; Tetrazoles	1997
Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. British journal of pharmacology, 1997, Volume: 122, Issue:7 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzofurans; Blood Pressure; Cyclic GMP; Drug Interactions; Enalapril; Enzyme Inhibitors; Hydralazine; Hypertension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Purinones; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	1997
Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 1997, Volume: 45, Issue:9 Topics: Animals; Antihypertensive Agents; Blood Pressure; Enalapril; Heart; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Myocardium; Nifedipine; Organ Size; Rats; Rats, Inbred SHR; RNA, Messenger	1997
Hemodynamic changes during administration of drugs for mitral regurgitation in dogs. The Journal of veterinary medical science, 1998, Volume: 60, Issue:2 Topics: Animals; Captopril; Cardiotonic Agents; Digoxin; Dog Diseases; Dogs; Echocardiography, Doppler, Color; Enalapril; Hemodynamics; Hydralazine; Mitral Valve Insufficiency; Prazosin; Vasodilator Agents	1998
Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Sep-15, Volume: 55, Issue:18 Topics: Alprazolam; Chloroquine; Chromatography, High Pressure Liquid; Cisapride; Drug Compounding; Drug Stability; Enalapril; Hydralazine; Pharmaceutical Solutions	1998
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Cardiomegaly; Data Interpretation, Statistical; DNA; DNA Fragmentation; Enalapril; Hemodynamics; Hydralazine; Losartan; Male; Nifedipine; Propranolol; Rats; Time Factors	1999
Potassium channel modulators and indomethacin-induced gastric ulceration in rats. Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:10 Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Diazoxide; Enalapril; Gastric Mucosa; Glyburide; Hydralazine; Indomethacin; Male; Peptic Ulcer; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents	1999
Hypertension and renal injury in experimental polycystic kidney disease. Kidney international, 1999, Volume: 56, Issue:6 Topics: Angiotensin II; Animals; Antihypertensive Agents; Enalapril; Fibrosis; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; Polycystic Kidney, Autosomal Dominant; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Vasoconstrictor Agents	1999
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats. Journal of hypertension, 1999, Volume: 17, Issue:12 Pt 2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Diuretics; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertrophy; Kidney; Male; Proteinuria; Rats; Rats, Inbred SHR; Reserpine; Sodium Chloride Symporter Inhibitors	1999
Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4 Topics: Acetylcholine; Administration, Oral; Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biological Factors; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Heart Rate; Hydralazine; Hydrochlorothiazide; In Vitro Techniques; Male; Mesenteric Arteries; Nitric Oxide Synthase; Norepinephrine; Rats; Rats, Inbred WKY; Vasodilation	2000
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. The Journal of clinical investigation, 2001, Volume: 107, Issue:8 Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Enalapril; Furosemide; Guanylate Cyclase; Hydralazine; Losartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Organ Size; Propranolol; Receptors, Atrial Natriuretic Factor; Telemetry; Ventricular Dysfunction, Left	2001
The influence of chronic antihypertensive treatment on the central pressor response in SHR. Hypertension research : official journal of the Japanese Society of Hypertension, 2001, Volume: 24, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Brain; Enalapril; Epinephrine; Heart Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Injections, Intraventricular; Losartan; Male; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Saline Solution, Hypertonic; Tetrazoles	2001
Antihypertensive drugs induce structural remodeling of the penile vasculature. The Journal of urology, 2001, Volume: 166, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Enalapril; Hydralazine; Male; Methoxamine; Penis; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins; Ventricular Remodeling	2001
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation, 2001, Nov-20, Volume: 104, Issue:21 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Dogs; Electrophysiology; Enalapril; Endomyocardial Fibrosis; Heart Atria; Heart Failure; Hemodynamics; Hydralazine; Isosorbide Dinitrate; Mitogen-Activated Protein Kinases; Renin-Angiotensin System; Signal Transduction; Tachycardia, Ventricular	2001
Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. Pediatric research, 2002, Volume: 52, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Apoptosis; bcl-X Protein; Clusterin; Enalapril; Female; Glycoproteins; Heart; Hydralazine; In Situ Nick-End Labeling; Molecular Chaperones; Myocardium; Pregnancy; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Renin	2002
Persistent lowering of arterial pressure after continuous and intermittent therapy. Journal of hypertension, 2003, Volume: 21, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Heart Rate; Heart Ventricles; Hydralazine; Hydrochlorothiazide; Hypertension; Losartan; Male; Nifedipine; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vasodilator Agents	2003
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (London, England), 2003, Mar-29, Volume: 361, Issue:9363 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Weight Loss	2003
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension. Journal of hypertension, 2003, Volume: 21, Issue:9 Topics: Age Factors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Brain; Enalapril; Hydralazine; Hypertension; Losartan; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Vasodilator Agents	2003
Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. Kidney international, 2004, Volume: 65, Issue:1 Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Glomerulosclerosis, Focal Segmental; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Male; Monitoring, Physiologic; Nephrectomy; Rats; Rats, Sprague-Dawley; Reserpine; Telemetry	2004
Race-based therapeutics. The New England journal of medicine, 2004, Nov-11, Volume: 351, Issue:20 Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Drug Approval; Drug Combinations; Drug Industry; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide Donors; Patents as Topic; Pharmacogenetics; United States; United States Food and Drug Administration; Vasodilator Agents	2004
Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats. Journal of hypertension, 2006, Volume: 24, Issue:1 Topics: Aging; Animals; Antihypertensive Agents; Apomorphine; Blood Pressure; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Transplantation; Losartan; Male; Nifedipine; Penile Erection; Random Allocation; Rats; Rats, Inbred SHR; Testosterone	2006
ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats. Vascular pharmacology, 2006, Volume: 44, Issue:6 Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cysteine; Dinoprost; Dose-Response Relationship, Drug; Enalapril; Femoral Artery; Glutathione Disulfide; Hydralazine; Hypertension; Male; Nitric Oxide Donors; Oxidative Stress; Rats; Rats, Inbred SHR; S-Nitrosothiols; Splanchnic Circulation; Vascular Resistance; Vasodilation; Vasodilator Agents	2006
Prescribing BiDil: is it black and white? Journal of the American College of Cardiology, 2006, Jul-04, Volume: 48, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Drug Approval; Drug Combinations; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Treatment Outcome; United States; United States Food and Drug Administration; White People	2006
Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection. Journal of hypertension, 2007, Volume: 25, Issue:4 Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Area Under Curve; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Circadian Rhythm; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Hemoglobins; Hydralazine; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Wistar; Reperfusion; Telemetry; Tetrazoles	2007
Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance. American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Cortex; Kidney Medulla; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Reserpine; Sodium; Sodium Chloride Symporters; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins, Type II; Sodium-Potassium-Chloride Symporters	2007
Role of cardiac hypertrophy in reducing the sensitivity of cardiopulmonary reflex control of renal sympathetic nerve activity in spontaneously hypertensive rats. Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:9 Topics: Animals; Antihypertensive Agents; Baroreflex; Body Weight; Cardiomegaly; Enalapril; Heart; Hemodynamics; Hydralazine; Hypertension; Kidney; Lung; Male; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke Volume; Sympathetic Nervous System	2008
"Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:1 Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Hydralazine; Hypertension; Hypertrophy; Kidney; Male; Matrix Metalloproteinase 13; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Tetrazoles; Vasodilator Agents	2009
Bradykinin B2 receptor-dependent enhancement of enalapril-evoked hypotension in ethanol-fed female rats. Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:1 Topics: Animals; Baroreflex; Bradykinin; Clonidine; Enalapril; Ethanol; Female; Hemodynamics; Hydralazine; Hypotension; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Telemetry	2011
Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 64, Issue:4 Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Nephrosclerosis; Rats; Rats, Inbred SHR; Reference Values; Treatment Outcome	2014
Effects of Renin-Angiotensin System Inhibitors on Renal Expression of Renalase in Sprague-Dawley Rats Fed With High Salt Diet. Kidney & blood pressure research, 2015, Volume: 40, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diet; Enalapril; Hydralazine; Kidney; Male; Monoamine Oxidase; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Valsartan	2015
Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety. BMJ open quality, 2019, Volume: 8, Issue:4 Topics: Administration, Intravenous; Antihypertensive Agents; Enalapril; Female; Health Personnel; Hospitals; Humans; Hydralazine; Hypertension; Labetalol; Patient Safety; Quality Improvement; Retrospective Studies	2019